This review summarizes the most clinically relevant genetic biomarkers currently used in colorectal cancer, including microsatellite instability, RAS and BRAF mutations, HER2 amplification, and NTRK fusions, while also discussing emerging biomarkers such as circulating tumor DNA, tumor mutational burden, transcriptomic...
C. Macrea, Tiberia Ilias, Alexandra Costea et al.· Cancers· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.